These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27384482)

  • 1. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
    Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
    Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.
    Zhang H; Hao C; Wang Y; Ji S; Zhang X; Zhang W; Zhao Q; Sun J; Hao J
    Mol Carcinog; 2016 Jul; 55(7):1127-37. PubMed ID: 26153894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.
    Zhang X; Liu R; Zhao N; Ji S; Hao C; Cui W; Zhang R; Hao J
    Mol Carcinog; 2019 Jun; 58(6):1008-1018. PubMed ID: 30720232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.
    Cui W; Xiao Y; Zhang R; Zhao N; Zhang X; Wang F; Liu Y; Zhang X; Hao J
    Mol Cancer Res; 2021 Sep; 19(9):1498-1509. PubMed ID: 34158392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Umbilical Cord Mesenchymal Stem Cells Promote Breast Cancer Metastasis by Interleukin-8- and Interleukin-6-Dependent Induction of CD44(+)/CD24(-) Cells.
    Ma F; Chen D; Chen F; Chi Y; Han Z; Feng X; Li X; Han Z
    Cell Transplant; 2015; 24(12):2585-99. PubMed ID: 25695620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular ATP promotes breast cancer invasion and epithelial-mesenchymal transition via hypoxia-inducible factor 2α signaling.
    Yang H; Geng YH; Wang P; Zhou YT; Yang H; Huo YF; Zhang HQ; Li Y; He HY; Tian XX; Fang WG
    Cancer Sci; 2019 Aug; 110(8):2456-2470. PubMed ID: 31148343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
    Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
    Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
    Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
    Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Liu F; Zhang H; Song H
    Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling.
    Li J; Hu L; Zhou T; Gong X; Jiang R; Li H; Kuang G; Wan J; Li H
    Life Sci; 2019 Sep; 232():116617. PubMed ID: 31260685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-β1.
    Zhang Z; Lin M; Wang J; Yang F; Yang P; Liu Y; Chen Z; Zheng Y
    Aging (Albany NY); 2021 Jun; 13(12):16009-16023. PubMed ID: 34096887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.